150 related articles for article (PubMed ID: 33109400)
1. Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.
Liang GB; Wei JH; Jiang H; Huang RZ; Qin JT; Wang HL; Wang HS; Zhang Y
Eur J Med Chem; 2021 Jan; 210():112951. PubMed ID: 33109400
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of 3-nitro-1,8-naphthalimides as potential antitumor agents.
Xin M; Wei JH; Yang CH; Liang GB; Su D; Ma XL; Zhang Y
Bioorg Med Chem Lett; 2020 Apr; 30(8):127051. PubMed ID: 32111436
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction.
Wang H; Wei J; Jiang H; Zhang Y; Jiang C; Ma X
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800091
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and antitumor evaluation of morpholine substituted bisnaphthalimides as DNA targeting agents.
Chen XM; Zhou JY; Liu SQ; Song LH; Wang HL; Wang Q; Liang SM; Lu L; Wei JH; Huang R; Zhang Y
Bioorg Med Chem Lett; 2023 Apr; 85():129218. PubMed ID: 36894107
[TBL] [Abstract][Full Text] [Related]
5. 7b, a novel amonafide analog, inhibited proliferation and phorbol 12-myristate 13-acetate/phytohemagglutinin-induced inflammatory responses of Jurkat T cells via p73-dependent pathway and decrease of nuclear factor-κB DNA-binding, respectively.
Shao J; Li Y; Shen K; Lin B; Xu Y; Lu Y; Yin P; Li Q; Liu J; Qian X
Leuk Lymphoma; 2013 Feb; 54(2):359-71. PubMed ID: 22762546
[TBL] [Abstract][Full Text] [Related]
6. Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.
Tan S; Yin H; Chen Z; Qian X; Xu Y
Eur J Med Chem; 2013 Apr; 62():130-8. PubMed ID: 23353750
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Activity and Topoisomerase II Inhibition of Naphthalimides with ω-Hydroxylalkylamine Side-Chains of Different Lengths.
Tomczyk MD; Byczek-Wyrostek A; Strama K; Wawszków M; Kasprzycki P; Walczak KZ
Med Chem; 2019; 15(5):550-560. PubMed ID: 30207241
[TBL] [Abstract][Full Text] [Related]
8. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.
Liu QQ; Lu K; Zhu HM; Kong SL; Yuan JM; Zhang GH; Chen NY; Gu CX; Pan CX; Mo DL; Su GF
Eur J Med Chem; 2019 Mar; 165():293-308. PubMed ID: 30685528
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance.
Liang SM; Liang GB; Wang HL; Jiang H; Ma XL; Wei JH; Huang RZ; Zhang Y
Eur J Med Chem; 2024 Jan; 263():115937. PubMed ID: 37972528
[TBL] [Abstract][Full Text] [Related]
10. A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis.
Chen Z; Liang X; Zhang H; Xie H; Liu J; Xu Y; Zhu W; Wang Y; Wang X; Tan S; Kuang D; Qian X
J Med Chem; 2010 Mar; 53(6):2589-600. PubMed ID: 20170164
[TBL] [Abstract][Full Text] [Related]
11. Novel naphthalimide derivatives as potential apoptosis-inducing agents: design, synthesis and biological evaluation.
Wu A; Xu Y; Qian X; Wang J; Liu J
Eur J Med Chem; 2009 Nov; 44(11):4674-80. PubMed ID: 19643513
[TBL] [Abstract][Full Text] [Related]
12. Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.
Wu A; Mei P; Xu Y; Qian X
Chem Biol Drug Des; 2011 Dec; 78(6):941-7. PubMed ID: 21958160
[TBL] [Abstract][Full Text] [Related]
13. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway.
Xie SQ; Zhang YH; Li Q; Xu FH; Miao JW; Zhao J; Wang CJ
Apoptosis; 2012 Jul; 17(7):725-34. PubMed ID: 22395446
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and cytotoxicity evaluation of naphthalimide derived N-mustards.
Lou Q; Ji L; Zhong W; Li S; Yu S; Li Z; Meng X
Molecules; 2014 Jun; 19(7):8803-19. PubMed ID: 24968335
[TBL] [Abstract][Full Text] [Related]
15. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, electrochemistry, DNA binding and in vitro cytotoxic activity of tripodal ferrocenyl bis-naphthalimide derivatives.
Fan YR; Wang BJ; Jia DG; Yang XB; Huang Y
J Inorg Biochem; 2021 Jun; 219():111425. PubMed ID: 33831713
[TBL] [Abstract][Full Text] [Related]
17. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
[TBL] [Abstract][Full Text] [Related]
18. New pyranopyrazole based derivatives: Design, synthesis, and biological evaluation as potential topoisomerase II inhibitors, apoptotic inducers, and antiproliferative agents.
Sobh EA; Kassab AE; El-Khouly EA; S A Hassan M
Bioorg Chem; 2024 Mar; 144():107158. PubMed ID: 38301427
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of naphthalimide-carborane and metallacarborane conjugates: Anticancer activity, DNA binding ability.
Nekvinda J; Różycka D; Rykowski S; Wyszko E; Fedoruk-Wyszomirska A; Gurda D; Orlicka-Płocka M; Giel-Pietraszuk M; Kiliszek A; Rypniewski W; Bachorz R; Wojcieszak J; Grüner B; Olejniczak AB
Bioorg Chem; 2020 Jan; 94():103432. PubMed ID: 31776032
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and evaluation of acridone-naphthalimide derivatives for regulating oncogene PDGFR-β expression.
Zhang M; Wei Z; Gong X; Li X; Kang S; Wang J; Liu B; Huang ZS; Li D
Bioorg Med Chem; 2021 Mar; 34():116042. PubMed ID: 33561716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
